Sacral Nerve Stimulation Market Size, Share, Industry Trends and Forecast to 2030

Sacral Nerve Stimulation Market Size & CAGR in 2021

The global sacral nerve stimulation market is expected to have a growth rate of 4.2% CAGR in 2021. The market size is anticipated to reach USD 582.3 million by the end of the year, showcasing steady growth in the industry.

COVID-19 Impact on the Sacral Nerve Stimulation Market

The COVID-19 pandemic has had a significant impact on the sacral nerve stimulation market. Due to the lockdowns and restrictions imposed during the pandemic, there was a temporary slowdown in the market growth. However, with the gradual reopening of economies and the resumption of elective procedures, the market is expected to recover steadily.

Sacral Nerve Stimulation Dynamics

Sacral nerve stimulation is a treatment option for patients with urinary and fecal incontinence, overactive bladder, and other pelvic floor disorders. The market dynamics of sacral nerve stimulation include increasing prevalence of pelvic floor disorders, growing awareness about minimally invasive treatment options, and advancements in technology for neuromodulation therapies.

Segments and Related Analysis

By Product Type

The sacral nerve stimulation market is segmented based on product type, including implantable pulse generators and leads. Implantable pulse generators held a significant market share in 2021, driven by the increasing adoption of these devices for the management of pelvic floor disorders.

By Application

The market is segmented by application into urinary incontinence, fecal incontinence, and overactive bladder. Urinary incontinence accounted for the largest share in 2021, due to the high prevalence of this condition and the efficacy of sacral nerve stimulation in its management.

By Region Analysis

The sacral nerve stimulation market is analyzed regionally, with North America leading the market in 2021 due to the presence of key market players, advanced healthcare infrastructure, and high adoption rate of innovative medical technologies. Europe and Asia Pacific are also significant regions in the market, showing promising growth opportunities.

Key Market Players and Competitive Landscape

Some of the key players in the sacral nerve stimulation market include Medtronic, Boston Scientific Corporation, Axonics Modulation Technologies, and Nevro Corp. These companies are focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their market position.

Recent Happenings in the Sacral Nerve Stimulation Market

- In October 2021, Axonics Modulation Technologies announced the FDA approval for its next-generation implantable neurostimulator for sacral neuromodulation therapy. - In August 2021, Boston Scientific Corporation introduced a new recharge-free implantable sacral neuromodulation system for the treatment of bladder control issues. - In January 2021, Medtronic acquired the company Stimgenics to expand its portfolio of neuromodulation therapies, including sacral nerve stimulation.